Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rLH supplementation in women with low mid- to late-follicular LH during IVF/ICSI stimulation
ChiCTR2100043606Phase 4Recruiting
- Sponsor
- West China Second University Hospital
- Start
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in infertility comparing rFSH+rLH with rFSH (2 arms). Primary endpoints: Number of oocytes retrieved and Number of embryos available. Started Mar 2021; status: recruiting.
02
Drugs
lutropin alfarecombinant human follicle stimulating hormone
03
Conditions
infertility
Beyond the preview
Go deeper on ChiCTR2100043606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043606.